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InTROduCTIOn Antibodies against Ku protein 
were first reported in 1981 in a patient with poly‑
myositis/scleroderma overlap syndrome. At that 
time the term Ku was derived from the initials 
of the patient’s name.1
The Ku protein is a heterodimer found main‑
ly in a cell nucleus and consists of two subunits 
with mass of 70kD (p70) and 86kD (p86), which 
attach to the terminal sections of double stranded 
DNA. This protein is a constituent of the DNA‑de‑
pendent protein kinase and plays an important 
role in the process of repair and recombination 
of DNA. It also participates in the regulation 
of gene transcription processes.2,3
The incidence of anti‑Ku antibodies is not so 
high. As few as 1 out of 3500 positive results for 
anti‑nuclear antibodies (ANA) is detected by im‑
munoblotting.4 When present, they usually reach 
a high titer (>1:10,000). Clinically, anti‑Ku an‑
tibodies are most often associated with symp‑
toms of muscle damage (myositis), skin (sclero-
dactylia, microstomia) and joint involvement and 
the presence of Raynaud’s syndrome, rarely lung 
fibrosis and disturbances in the upper gastroin‑
testinal tract.5,6
Of note, there exists a possibility of demo‑
graphic differences in clinical symptoms. An‑
ti‑Ku in the North American population (es‑
pecially in Afro‑Americans) is detected more 
frequently in patients with systemic lupus 
erythematosus (SLE), while in the European pop‑
ulation it is observed in patients with overlap syn‑
dromes (most commonly with scleroderma and 
polymyositis).7‑9
CASE REPORTS In 5 women hospitalized in 2007 
in the II Department of Internal Medicine, Jag‑
iellonian University Medical College in Kraków, 
ANA at a very high titer (>1:10,000) were detect‑
ed by indirect immunofluorescence (Myositis Pro‑
file test, Euroimmun, Germany), and the immu‑
noblot test confirmed the presence of anti‑Ku an‑
tibodies at high titers.
Patient number 1, aged 37, with SLE diagnosed 
in 2005, complained of osteoarticular pains, recur‑
rent left‑sided numbness of the face and tongue, 
and, transient hyperesthesia in this region. Mag‑
netic resonance imaging (MRI) of the brain was 
normal.
Patient number 2, aged 58, with a mixed con‑
nective tissue disease, accompanied with sicca 
syndrome and Raynaud’s symptoms diagnosed 
in 2006, presented muscle weakness of the shoul‑
der and hip girdles, muscle atrophy, bone and 
joint pain, numbness of the hands, scleroder‑
ma and persistent heartburn. Further studies 
revealed increased muscle enzyme activity and 
myoglobin level. pH‑metry showed gastroesoph‑
ageal reflux disease, and pulmonary fibrosis was 
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tomography. No anti‑Scl 70 antibodies were 
found.
Patient number 3, aged 47, with Sjögren’s 
syndrome diagnosed in 2007, apart from symp‑
toms of sicca syndrome and osteoarticular pains, 
complained of mouth twisting, inability to close 
her left eye lid and left‑sided facial hypoesthe‑
sia. The MRI of the brain was normal, and lab‑
oratory tests showed features of skeletal mus‑
cle damage.
Patient number 4, aged 69, with idiopath‑
ic pulmonary fibrosis diagnosed in 2002, apart 
from exertion dyspnea did not report any oth‑
er symptoms.
Patient number 5, aged 32, with the overlap 
syndrome diagnosed in 2007, i.e. polymyositis/
scleroderma, presented with typical symptoms 
of Raynaud’s syndrome, bone and joint pains, 
scleroderma (sclerodactylia, microstomia) with dig‑
ital pitting ulcers, muscle atrophy, along with fea‑
tures of skeletal muscle damage in laboratory 
tests. No anti‑Scl 70 antibodies were reported.
dISCuSSIOn The cases described in this paper 
reflect the variety of clinical manifestations ob‑
served in patients with auto immune diseases hav‑
ing anti‑Ku antibodies (TAblE).
Firstly, the gender of patients should be men‑
tioned because all the cases reported were wom‑
en. Secondly, a broad spectrum of symptoms as‑
sociated with anti‑Ku antibodies does not allow 
us to assume that these antibodies are pathog‑
nomonic for any particular connective tissue 
disease. However, the analysis of these 5 cas‑
es seems to corroborate previous reports7,8 that 
the presence of anti‑Ku antibodies in the Euro‑
pean population shows more commonly asso‑
ciation with symptoms of polymyositis‑sclero‑
derma overlap syndrome than with SLE. Thirdly, 
if anti‑Ku antibodies have been identified, their 
titer is high, more than 1:10,000. With the ex‑
ception of anti‑small nuclear ribonucleoprotein 
particles (anti‑snRNP) antibodies, it is very rare 
that any other antibodies reach such a high titer. 
It should also be emphasized that usually other 
types of antibodies, except for anti‑Ro52, do not 
coexist with anti‑Ku antibodies.
The clinical symptoms associated with anti‑
‑Ku antibodies which have not been reported 
so far, are transient symptoms of cranial neu‑
ropathy involving trigeminal and facial nerves 
in 3 out of the 5 patients studied. It needs 
to be emphasized that these subjective com‑
plaints were short lasting, difficult to document 
in the MRI or in functional tests (electromyog‑
raphy), and they subsided spontaneously. Fur‑
ther studies are necessary to determine to which 
extent indeed they are typical of the presence 
of anti‑Ku antibodies.
In conclusion, it should be stated that anti‑
‑Ku antibodies occur in a variety of systemic auto‑
immune diseases and are characteristic of none 
of them. Among patients with anti‑Ku women 
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sera reach high titers. Clinically, they may pres‑
ent a variety of nonspecific symptoms – most of‑
ten with myositis, skin lesions typical of sclero‑
derma, osteoarticular pains, symptoms of sicca 
syndrome and Raynaud’s syndrome, cranial poly‑
neuropathy, and far less commonly – pulmonary 
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